CN101406688B - 一种治疗风湿、类风湿性关节炎的复方制剂 - Google Patents
一种治疗风湿、类风湿性关节炎的复方制剂 Download PDFInfo
- Publication number
- CN101406688B CN101406688B CN2008102336539A CN200810233653A CN101406688B CN 101406688 B CN101406688 B CN 101406688B CN 2008102336539 A CN2008102336539 A CN 2008102336539A CN 200810233653 A CN200810233653 A CN 200810233653A CN 101406688 B CN101406688 B CN 101406688B
- Authority
- CN
- China
- Prior art keywords
- parts
- rheumatoid arthritis
- portions
- compound preparation
- rheumathritis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 206010039073 rheumatoid arthritis Diseases 0.000 title claims abstract description 21
- 150000001875 compounds Chemical class 0.000 title claims abstract description 11
- 238000009472 formulation Methods 0.000 title abstract description 4
- 239000000203 mixture Substances 0.000 title abstract description 4
- 201000003068 rheumatic fever Diseases 0.000 title 1
- 238000002360 preparation method Methods 0.000 claims abstract description 19
- 239000002994 raw material Substances 0.000 claims abstract description 12
- 239000007788 liquid Substances 0.000 claims abstract description 10
- 241000271042 Gloydius halys Species 0.000 claims description 17
- 239000002552 dosage form Substances 0.000 claims description 3
- 230000000694 effects Effects 0.000 abstract description 17
- 239000003814 drug Substances 0.000 abstract description 11
- 229940079593 drug Drugs 0.000 abstract description 7
- 238000012360 testing method Methods 0.000 abstract description 3
- 210000002808 connective tissue Anatomy 0.000 abstract description 2
- 230000006378 damage Effects 0.000 abstract description 2
- 235000013305 food Nutrition 0.000 abstract description 2
- 230000036285 pathological change Effects 0.000 abstract description 2
- 238000012216 screening Methods 0.000 abstract description 2
- 231100000331 toxic Toxicity 0.000 abstract description 2
- 230000002588 toxic effect Effects 0.000 abstract description 2
- 244000189799 Asimina triloba Species 0.000 abstract 2
- 235000006264 Asimina triloba Nutrition 0.000 abstract 2
- 235000009467 Carica papaya Nutrition 0.000 abstract 2
- 241000270273 Ptyas dhumnades Species 0.000 abstract 2
- 241000271897 Viperidae Species 0.000 abstract 2
- 244000223760 Cinnamomum zeylanicum Species 0.000 abstract 1
- 244000273928 Zingiber officinale Species 0.000 abstract 1
- 235000006886 Zingiber officinale Nutrition 0.000 abstract 1
- 210000000988 bone and bone Anatomy 0.000 abstract 1
- 235000017803 cinnamon Nutrition 0.000 abstract 1
- 235000008397 ginger Nutrition 0.000 abstract 1
- 108060008682 Tumor Necrosis Factor Proteins 0.000 description 8
- 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 description 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 8
- 238000009835 boiling Methods 0.000 description 7
- 238000000605 extraction Methods 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- 241000700159 Rattus Species 0.000 description 6
- 244000052769 pathogen Species 0.000 description 6
- 239000002671 adjuvant Substances 0.000 description 5
- 206010003246 arthritis Diseases 0.000 description 5
- 210000002683 foot Anatomy 0.000 description 5
- 230000008961 swelling Effects 0.000 description 5
- 208000024891 symptom Diseases 0.000 description 5
- 102000003777 Interleukin-1 beta Human genes 0.000 description 4
- 108090000193 Interleukin-1 beta Proteins 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 238000012856 packing Methods 0.000 description 4
- 208000009386 Experimental Arthritis Diseases 0.000 description 3
- 238000004140 cleaning Methods 0.000 description 3
- 239000012141 concentrate Substances 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 239000003826 tablet Substances 0.000 description 3
- MZOFCQQQCNRIBI-VMXHOPILSA-N (3s)-4-[[(2s)-1-[[(2s)-1-[[(1s)-1-carboxy-2-hydroxyethyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-3-[[2-[[(2s)-2,6-diaminohexanoyl]amino]acetyl]amino]-4-oxobutanoic acid Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@@H](N)CCCCN MZOFCQQQCNRIBI-VMXHOPILSA-N 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 102000000589 Interleukin-1 Human genes 0.000 description 2
- 108010002352 Interleukin-1 Proteins 0.000 description 2
- 102000003814 Interleukin-10 Human genes 0.000 description 2
- 108090000174 Interleukin-10 Proteins 0.000 description 2
- 102000004388 Interleukin-4 Human genes 0.000 description 2
- 108090000978 Interleukin-4 Proteins 0.000 description 2
- 206010023232 Joint swelling Diseases 0.000 description 2
- 206010036030 Polyarthritis Diseases 0.000 description 2
- 208000019802 Sexually transmitted disease Diseases 0.000 description 2
- 239000003146 anticoagulant agent Substances 0.000 description 2
- 210000000544 articulatio talocruralis Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 229940028885 interleukin-4 Drugs 0.000 description 2
- 210000002540 macrophage Anatomy 0.000 description 2
- 230000004089 microcirculation Effects 0.000 description 2
- 231100000957 no side effect Toxicity 0.000 description 2
- 239000000041 non-steroidal anti-inflammatory agent Substances 0.000 description 2
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 description 2
- 210000003024 peritoneal macrophage Anatomy 0.000 description 2
- 208000030428 polyarticular arthritis Diseases 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 230000001629 suppression Effects 0.000 description 2
- 210000001226 toe joint Anatomy 0.000 description 2
- 208000006820 Arthralgia Diseases 0.000 description 1
- 208000036487 Arthropathies Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 208000012659 Joint disease Diseases 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 230000002917 arthritic effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000000916 dilatatory effect Effects 0.000 description 1
- 239000008298 dragée Substances 0.000 description 1
- -1 electuary Substances 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 239000002662 enteric coated tablet Substances 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 239000007941 film coated tablet Substances 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229940076144 interleukin-10 Drugs 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000007901 soft capsule Substances 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000007940 sugar coated tablet Substances 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000002537 thrombolytic effect Effects 0.000 description 1
- 231100000820 toxicity test Toxicity 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Description
组别 | IL-1β(A570nm) | TNF-α(ng/L) |
空白对照组 | 0.334±0.090 | 246.15±39.83 |
模型组 | 0.733±0.074<sup>**</sup> | 387.56±30.17<sup>**</sup> |
风湿骨痛丸组 | 0.551±0.060<sup>△△</sup> | 311.67±48.69<sup>△△</sup> |
本产品组 | 0.503±0.084<sup>△△</sup> | 305.22±35.31<sup>△△</sup> |
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2008102336539A CN101406688B (zh) | 2008-11-28 | 2008-11-28 | 一种治疗风湿、类风湿性关节炎的复方制剂 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2008102336539A CN101406688B (zh) | 2008-11-28 | 2008-11-28 | 一种治疗风湿、类风湿性关节炎的复方制剂 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101406688A CN101406688A (zh) | 2009-04-15 |
CN101406688B true CN101406688B (zh) | 2010-12-22 |
Family
ID=40570033
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2008102336539A Active CN101406688B (zh) | 2008-11-28 | 2008-11-28 | 一种治疗风湿、类风湿性关节炎的复方制剂 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101406688B (zh) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104740425B (zh) * | 2015-03-03 | 2018-01-30 | 成都岷江源药业股份有限公司 | 一种治疗风湿痹症的药物组合物及其制备方法和用途 |
CN105287815A (zh) * | 2015-10-29 | 2016-02-03 | 杨有冬 | 一种复方生物蛇片 |
CN105287636A (zh) * | 2015-10-29 | 2016-02-03 | 杨有冬 | 一种治疗自身免疫性疾病的生物蛇粉组合物 |
CN105520133A (zh) * | 2015-12-15 | 2016-04-27 | 山东海波海洋生物科技股份有限公司 | 一种抗疲劳和激活机体免疫力、抵抗力的保健功能食品及其制备方法 |
CN105477453A (zh) * | 2016-01-19 | 2016-04-13 | 张龙武 | 一种治疗风湿、类风湿的中药配方 |
CN106177092A (zh) * | 2016-08-24 | 2016-12-07 | 尹艳军 | 一种治疗颈痛和腰痛的中药组合物及其制备方法 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1173365A (zh) * | 1997-07-30 | 1998-02-18 | 张巨文 | 一种治疗风湿、类风湿病的中药制剂及其制备方法 |
CN1175450A (zh) * | 1997-07-20 | 1998-03-11 | 迟经惠 | 风湿关节膏 |
CN1175433A (zh) * | 1996-08-30 | 1998-03-11 | 郭文钦 | 一种治疗类风湿性关节炎的药物及其生产方法 |
CN1317332A (zh) * | 2000-04-08 | 2001-10-17 | 黄贺胜 | 五蛇风湿保健酒 |
CN1935012A (zh) * | 2006-09-21 | 2007-03-28 | 张志祥 | 木瓜桃仁胶囊及其制备工艺 |
-
2008
- 2008-11-28 CN CN2008102336539A patent/CN101406688B/zh active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1175433A (zh) * | 1996-08-30 | 1998-03-11 | 郭文钦 | 一种治疗类风湿性关节炎的药物及其生产方法 |
CN1175450A (zh) * | 1997-07-20 | 1998-03-11 | 迟经惠 | 风湿关节膏 |
CN1173365A (zh) * | 1997-07-30 | 1998-02-18 | 张巨文 | 一种治疗风湿、类风湿病的中药制剂及其制备方法 |
CN1317332A (zh) * | 2000-04-08 | 2001-10-17 | 黄贺胜 | 五蛇风湿保健酒 |
CN1935012A (zh) * | 2006-09-21 | 2007-03-28 | 张志祥 | 木瓜桃仁胶囊及其制备工艺 |
Also Published As
Publication number | Publication date |
---|---|
CN101406688A (zh) | 2009-04-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN100998843A (zh) | 一种治疗胆囊炎的药物组合物 | |
CN101406688B (zh) | 一种治疗风湿、类风湿性关节炎的复方制剂 | |
CN101810835A (zh) | 一种治疗紫癜的中药组合物及其制备方法 | |
CN100355450C (zh) | 秦川通痹片 | |
CN103405582B (zh) | 改善类风湿关节炎关节肿痛的中药组合物 | |
CN104815318A (zh) | 一种治疗痛风的中药制剂 | |
CN102008621B (zh) | 治疗精神药物所致闭经的中药丸剂 | |
CN106215046A (zh) | 一种治疗急性痛风性关节炎的中药 | |
CN103405653B (zh) | 治疗痛风性关节炎的外用制剂 | |
CN103550688B (zh) | 一种治疗心悸的中药组合物 | |
CN104491459A (zh) | 一种治疗肿瘤的中药组合物 | |
CN108619427B (zh) | 一种预防治疗痛风性关节炎的祛痛降酸药茶 | |
CN103169745A (zh) | 治疗血尿的中药组合物及其用途 | |
CN105288501A (zh) | 一种含有艾叶的治疗肥胖症的中药制剂 | |
CN1879722A (zh) | 一种治疗风湿性关节炎的药物 | |
CN100367997C (zh) | 一种治疗痛风病的药物及其制备方法 | |
CN104306948A (zh) | 一种治疗痛风性关节炎的药物组合物 | |
CN106266152A (zh) | 一种治疗湿疹的药物组合物及其制备方法和用途 | |
CN106620435A (zh) | 治疗痛风性关节炎的中药组合物及其应用 | |
CN107007652A (zh) | 康复新液联合中药在制备治疗不孕症的药物中的用途 | |
CN106038812A (zh) | 用于降血脂、祛除动脉粥样硬化斑块的中药胶囊 | |
CN105641633A (zh) | 一种中药制剂在制备治疗肥胖症的药物中的用途 | |
CN104984166A (zh) | 一种治疗阴囊湿疹的护理用药物及其制备方法 | |
CN104958574A (zh) | 一种治疗脑震荡的中药制剂及其制备方法 | |
CN105288396A (zh) | 一种治疗气滞血瘀型原发性骨质疏松症的中药及制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
EE01 | Entry into force of recordation of patent licensing contract |
Assignee: Yunnan crystal Natural Pharmaceutical Co. Ltd. Assignor: Wei Yuling Contract record no.: 2011530000056 Denomination of invention: Compound formulation for treating rheumatic arthritis and rheumatoid arthritis Granted publication date: 20101222 License type: Exclusive License Open date: 20090415 Record date: 20110805 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20160106 Address after: 650041, Jintai building, No. 48 Dongfeng Dong Road, Kunming, Yunnan, 906, Kunming Patentee after: Yunnan crystal Natural Pharmaceutical Co. Ltd. Address before: 650041, Jintai building, No. 48 Dongfeng Dong Road, Yunnan, Kunming, 906 Patentee before: Wei Yuling |
|
C56 | Change in the name or address of the patentee | ||
CP01 | Change in the name or title of a patent holder |
Address after: 650041, Jintai building, No. 48 Dongfeng Dong Road, Yunnan, Kunming, 906 Patentee after: YUNNAN CRYSTAL NATURAL PHARMACEUTICAL CO., LTD. Address before: 650041, Jintai building, No. 48 Dongfeng Dong Road, Yunnan, Kunming, 906 Patentee before: Yunnan crystal Natural Pharmaceutical Co. Ltd. |
|
CP01 | Change in the name or title of a patent holder | ||
CP01 | Change in the name or title of a patent holder |
Address after: 650041, Jintai building, No. 48 Dongfeng Dong Road, Yunnan, Kunming, 906 Patentee after: Sailing Pharmaceutical Technology Group Co., Ltd Address before: 650041, Jintai building, No. 48 Dongfeng Dong Road, Yunnan, Kunming, 906 Patentee before: Yunnan Kress Pharmaceutical Co.,Ltd. |